Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
National Center for Research Resources (NCRR)
With
University of North Carolina
PROTOCOL OUTLINE:
Patients begin a mycophenolate mofetil (MMF)-containing regimen within the first 5 days after transplantation. Patients have blood drawn on postoperative days 7, 21, 42, 70, 98, 126, and 154. Urine is collected on postoperative days 7, 21, and 42. Patients with T-tube bile externalization also have bile collected on postoperative day 7.
Age
19–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
PROTOCOL ENTRY CRITERIA:
-Disease Characteristics--
Orthotopic liver or kidney transplant recipients who started on a mycophenolate mofetil-containing immunosuppressive regimen within 5 days after transplant
Kidney transplant recipients will serve as study controls
-Prior/Concurrent Therapy--
No concurrent bile acid sequestrants
No mycophenolate mofetil as part of rescue therapy regimen
No concurrent albumin replacement therapy
-Patient Characteristics--
Renal: Urine output at least 500 mL/day OR Creatinine less than 2.5 mg/dL
Other:
Not pregnant
No mental incompetency
No prisoners or parolees HIV negative
No active infection defined as: Temperature above 101 F with WBC greater than 12,000/mm3 and left shift OR Two or more positive cultures of a single isolated organism from blood, urine, or sputum